Sapna Gangaputra (@gangaputrasapna) 's Twitter Profile
Sapna Gangaputra

@gangaputrasapna

Clinician scientist with expertise in adult and pediatric uveitis, clinical trials, international ophthalmology and ophthalmic epidemiology.

ID: 1178008794808410113

calendar_today28-09-2019 18:09:24

276 Tweet

134 Followers

200 Following

Ophthalmology (@aaojournal) 's Twitter Profile Photo

Large language models such as ChatGPT have the potential to generate their own health content as well as aid clinicians in improving the readability of already existing health content on #uveitis. Edmund Tsui, MD UCLA Stein Eye Institute ow.ly/lGOe50PMHHf

Large language models such as ChatGPT have the potential to generate their own health content as well as aid clinicians in improving the readability of already existing health content on #uveitis. <a href="/EdmundTsuiMD/">Edmund Tsui, MD</a> <a href="/UCLASteinEye/">UCLA Stein Eye Institute</a> ow.ly/lGOe50PMHHf
Drew Carey, Eye MD (@drewcareymd) 's Twitter Profile Photo

Dr. Jennifer Elizabeth Thorne, M.D., Ph.D. from Wilmer Eye Institute Johns Hopkins Medicine discusses Treatment of #Uveitis Macular Edema:  Lessons learned from POINT and MERIT at #PAAO2024 in San Juan, Puerto Rico #eyetwitter #retina

Dr. Jennifer Elizabeth Thorne, M.D., Ph.D. from Wilmer Eye Institute <a href="/HopkinsMedicine/">Johns Hopkins Medicine</a> discusses Treatment of #Uveitis Macular Edema:  Lessons learned from POINT and MERIT at #PAAO2024 in San Juan, Puerto Rico #eyetwitter #retina
Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Thank you @VUMCEye for inviting me to be a keynote speaker at the Carolyn Smith Uveitis Symposium. Had a great time presenting my research & also listening to the outstanding resident case presentations. 👏Dr. Sapna Gangaputra for organizing such a great symposium!

Thank you @VUMCEye for inviting me to be a keynote speaker at the Carolyn Smith Uveitis Symposium.

Had a great time presenting my research &amp; also listening to the outstanding resident case presentations.

👏Dr. <a href="/GangaputraSapna/">Sapna Gangaputra</a> for organizing such a great symposium!
Chris Cho, MD (@chrischo_md) 's Twitter Profile Photo

If you want anyone commenting on the business side of ophthalmology, Sean Berkowitz, MD, MBA is the guy!! Have a listen about the ever changing landscape of the ophthalmology work force! Edmund Tsui, MD @VUMCEye Avni Finn Shriji Patel, MD MBA

Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Our website is now live for the 2nd UCLA Stein Eye Institute Doheny Eye Institute & AUS International Workshop on Objective Measures of Intraocular Inflammation for Use in Clinical Trials. 📢Full agenda, registration, & abstract submission in the link below! mcpi.cventevents.com/event/2f90c72f…

Our website is now live for the 2nd <a href="/UCLASteinEye/">UCLA Stein Eye Institute</a> <a href="/DohenyEye/">Doheny Eye Institute</a> &amp; <a href="/UveitisSociety/">AUS</a> International Workshop on Objective Measures of Intraocular Inflammation for Use in Clinical Trials.

📢Full agenda, registration, &amp; abstract submission in the link below!

mcpi.cventevents.com/event/2f90c72f…
Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Very excited to be part of the inaugural cohort of the Council of Vision Editors Fellowship Program. I am looking forward to learning from editorial board members and contributing to the peer review process of these top #ophthalmology journals. NEI American Journal of Ophthalmology

The Lens: Ophthalmology Research Newsletter (@thelens_oph) 's Twitter Profile Photo

New findings from American Journal of Ophthalmology: Uveitic eyes show higher than reported PCME rates, yet most resolve within a year with low relapse risk! 📉 Read more at: pubmed.ncbi.nlm.nih.gov/38880375/ #Ophthalmology #Cataract #Uveitis Sapna Gangaputra

Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Our 2nd UCLA/AUS International Workshop on Objective Measures of Intraocular Inflammation in Clinical Trials starts this Friday! 🎉 Excited to showcase our lineup of speakers, research presentations, & panels. 📊🗣️ Check out the full agenda below 👇 mcpi.cventevents.com/ausworkshop2024

Our 2nd UCLA/AUS International Workshop on Objective Measures of Intraocular Inflammation in Clinical Trials starts this Friday! 🎉

Excited to showcase our lineup of speakers, research presentations, &amp; panels. 📊🗣️

Check out the full agenda below 👇
mcpi.cventevents.com/ausworkshop2024
Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Inspiring opening keynote by Michael F. Chiang, MD on “Pushing Boundaries through Data Science, Standards, and Collaboration: Perspectives from the National Eye Institute” today @ UCLA/AUS International Workshop on Objective Measures of Intraocular Inflammation in Clinical Trials.

Inspiring opening keynote by <a href="/NEIDirector/">Michael F. Chiang, MD</a> on “Pushing Boundaries through Data Science, Standards, and Collaboration: Perspectives from the National Eye Institute” today @ UCLA/AUS International Workshop on Objective Measures of Intraocular Inflammation in Clinical Trials.
Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Really enjoyed participating on the faculty at the Uveitis Fellows Forum last week. I presented on "Uveitis & Research in Academics" & shared my insights during the "Academic Practice" breakout sessions. There were great career talks by faculty & interactive cases by the fellows

Really enjoyed participating on the faculty at the Uveitis Fellows Forum last week.

I presented on "Uveitis &amp; Research in Academics" &amp; shared my insights during the "Academic Practice" breakout sessions. There were great career talks by faculty &amp; interactive cases by the fellows
Ophthalmology (@aaojournal) 's Twitter Profile Photo

Time-driven activity-based costing analysis of panretinal photocoagulation shows 47.8% of cases have a negative margin vs maximum Medicare reimbursement, with financial disincentives for bilateral cases, which may disincentivize this high value procedure. ow.ly/mcXm50UK7Wv

Time-driven activity-based costing analysis of panretinal photocoagulation shows 47.8% of cases have a negative margin vs maximum Medicare reimbursement, with financial disincentives for bilateral cases, which may disincentivize this high value procedure. ow.ly/mcXm50UK7Wv
Young Uveitis Specialists (@younguveitis) 's Twitter Profile Photo

Fresh eyes. Shared purpose. Bold future. Welcome to the Young Uveitis Specialists — your community for learning, collaboration, and advancing care in uveitis. Whether you’re navigating fellowship or shaping your early career, this space is built for you.

Fresh eyes. Shared purpose. Bold future.
Welcome to the Young Uveitis Specialists — your community for learning, collaboration, and advancing care in uveitis.

Whether you’re navigating fellowship or shaping your early career, this space is built for you.
Young Uveitis Specialists (@younguveitis) 's Twitter Profile Photo

Your uveitis story belongs here. Whether it’s a recent talk you gave, a local workshop you hosted, or just a small moment that made you love this field even more — we want to share it. DM us your experiences!

Your uveitis story belongs here.
Whether it’s a recent talk you gave, a local workshop you hosted, or just a small moment that made you love this field even more — we want to share it. 

DM us your experiences!
Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Excited to share our latest from the Multimodal Imaging in Uveitis (MUV) Taskforce in American Journal of Ophthalmology "Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis with Panuveitis and Punctate Inner Choroiditis", led by Sapna Gangaputra ajo.com/article/S0002-…

Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

✅Lesions of MFCPU and PIC can be well characterized using color photos ✅OCT is preferred modality for detecting active lesions ✅ FAF & OCT effective for monitoring disease recurrence ✅Late-phase ICGA valuable in recurrent disease when lesions are not visible on FAF & CFP